186
Views
0
CrossRef citations to date
0
Altmetric
Articles

Optimal Duration of Chemotherapy in Small Cell Lung Cancer: A Randomized Study of 4 versus 6 Cycles of Cisplatin-Etoposide

Pages 136-140 | Published online: 18 Jul 2013

References

  • Ettinger DS, Finkelstein DM, Abeloff MD et al. A ran-domized comparison of standard chemotherapy versus alter-nating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell lung cancer. A phase II study of the Eastern Cooperative Oncology Group. J Clin Oncol 1990, 8: 230–240.
  • Spiro SG, Souhami RL, Geddes DM. et al. Duration of chemotherapy in small cell lung cancer. A cancer research campaign trial. Br J Cancer 1989, 59: 578–583.
  • Roth BJ, Johsnon DH, Einhorn LH. et al. Randomized study of cyclophosphamide, doxorubicin and vincristine versus etoposide and cisplatin versus alternation of these two regi-mens in extensive small-cell lung cancer. A phase III trial of the Southeastern Cancer Study Group. J Clin Oncol 1992, 10: 282–291.
  • Armitage P, Berry G. Statistical methods in medical research. 2nd Ed. Blackwell Scientific Publications, London 1987, Chap. 14.
  • World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment Geneva WHO Offset Publication 1979, No 48.
  • Cox DR. Regression models and life-tables. J R Stat Soc 1972; B 34: 187-220.
  • Medical Council Research Lung Cancer Working Party. Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer. Br J Cancer 1989; 59: 584–590.
  • Medical Research Council Lung Cancer Working Party. A randomized trial of three or six courses of etoposide, cyclophosphamide, methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC) I: Survival and prognostic factors. Br J Cancer 1993; 68: 1150–1156.
  • Giaccone G, Dalesio 0, McVie GJ, et al. Maintenance chemotherapy in small cell lung cancer: long-term results of a randomized trial. J Clin Oncol 1993; 11: 1230-1240.
  • Slevin PM, Stead ML, Brown JM et al. A randomised trial of three versus six courses of etoposide, ifosfamide, mesna and vincristine in small cell lung cancer. For the Yorkshire Thoraxic Group Leeds, England. Lung Cancer 1997; 18 (Supp. I) #20 abstr.
  • Shepherd FA, Amdemichael E, Evans WK et al. Treatment of small cell lung cancer in the elderly. J Am Geriatr Soc 1994; 42: 64–70.
  • Medical Research Council Lung Cancer Working Party. Comparison of oral etoposide and standard intravenous mul-tidrug chemotherapy for small-cell lung cancer. A stopped multicenter trial. Lancet 1996; 348: 563–666.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.